Increasing solubility of proteins and peptides by site-specific modification with betaine

Bioconjugate Chemistry

Volumn 19, Issue 6, 2008, Pages 1113-1118

  Xiao, Junpeng ^a   Burn, Alex ^a   Tolbert, Thomas J ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CIRCULAR DICHROISM SPECTROSCOPY; DICHROISM; PEPTIDES; POLYPEPTIDES; SOLUBILITY;

BACTERIAL ENZYMES; BIOCHEMICAL STUDIES; GUANINE; N TERMINUS; N-TERMINALS; PHARMACEUTICAL APPLICATIONS; QUATERNARY AMMONIUM; SITE-SPECIFIC MODIFICATIONS; SMALL MOLECULES; TERMINAL CYSTEINE;

BETAINES;

AMMONIA; BETAINE; CYSTEINE; ENFUVIRTIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PEPTIDES AND PROTEINS; THIOESTER;

AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL MODIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID SOLUBILITY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN STRUCTURE; SPECTROSCOPY; TURBIDITY;

BACTERIA (MICROORGANISMS); TOBACCO ETCH VIRUS;

EID: 45749149625     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800063k     Document Type: Article

References (33)

1. Yee, A., Pardee, K., Christendat, D., Savchenko, A., Edwards, A. M., and Arrowsmith, C. H. (2003) Structural proteomics: Toward high-throughput structural biology as a tool in functional genomics. Acc. Chem. Res. 36, 183-189.
2. Biron, Z., Khare, S., Quadt, S. R., Hayek, Y., Naider, F., and Anglister, J. (2005) The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20. Biochemistry 44, 13602-13611.
3. Chi, E. Y., Krishnan, S., Randolph, T. W., and Carpenter, J. F. (2003) Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm. Res. 20, 1325-1336.
4. Fowler, S. B., Poon, S., Muff, R., Chiti, F., Dobson, C. M., and Zurdo, J. (2005) Rational design of aggregation-resistant bioactive peptides: Reengineering human calcitonin. Proc. Natl. Acad. Sci. U.S.A. 102, 10105-10110.
5. Taylor, J. P., Hardy, J., and Fischbeck, K. H. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991-1995.
6. Ross, C. A., and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease. Nat. Med. 10, S1-17.
7. Fink, A. L. (2006) The aggregation and fibrillation of α-synuclein. Acc. Chem. Res. 39, 628-634.
8. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptides. Nat. Rev. Mol. Cell. Biol. 8, 101-112.
9. Samuelsson, E., Moks, T., Nilsson, B., and Uhlen, M. (1994) Enhanced in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner. Biochemistry 33, 4207-4211.
10. Kapust, R. B., and Waugh, D. S. (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 8, 1668-1674.
11. Kataeva, I., Chang, J., Xu, H., Luan, C-H., Zhou, J., Uversky, V. N., Lin, D., Horanyi, P., Liu, Z. J., Ljungdahl, L. G., Rose, J., Luo, M., and Wang, B-C. (2005) Improving solubility of Shewanella oneidensis MR-1 and Clostridium thermocellum JW-20 proteins expressed into Esherichia coli. J. Proteome Res. 4, 1942-1951.
12. Luo, Y., Huang, X., and Mckeehan, W. L. (2007) High yield, purity and activity of soluble recombinant Bacteroides thetaiotaomicron GST-heparinase I from Escherichia coli. Arch. Biochem. Biophys. 460, 17-24.
13. Loose, C. R., Langer, R. S., and Stephanopoulos, G. N. (2007) Optimization of protein fusion partner length for maximizing in vitro translation of peptides. Biotechnol. Prog. 23, 444-451.
14. Sinclair, A. M., and Elliott, S. (2005) Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins. J. Pharm. Sci. 94, 1626-1635.
15. Pomroy, N. C., and Deber, C. M. (1999) Conjugation of polyethylene glycol via a disulfide bond confers water solubility upon a peptide model of a protein transmembrane segment. Anal. Biochem. 275, 224-230.
16. Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., Hua, J., Hsieh, M.-C., Zhou, J., Petti, G., Li, X., Janjua, A., Mendez, M., Liu, J., Longley, C., Zhang, Z., Mehlig, M., Borowski, V., Viswanathan, M., and Filpula, D. (2006) Structure-function engineering of interferon-β-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation. Bioconjugate Chem. 17, 618-630.
17. Marsac, Y., Cramer, J., Olschewski, D., Alexandrov, K., and Becker, C. F. (2006) Site-specific attachment of polyethylene glycol-like oligomers to proteins and peptides. Bioconjugate Chem. 17, 1492-1498.
18. Kato, A., Maki, K., Ebina, T., Kuwajima, K., Soda, K., and Kuroda, Y. (2007) Mutational analysis of protein solubility enhancement using short peptide tags. Biopolymers 85, 12-18.
19. Johnson, E. C., Malito, E., Shen, Y., Rich, D., Tang, W-J., and Kent, S. B. (2007) Modular total chemical synthesis of a human immunodeficiency virus type 1 protease. J. Am. Chem. Soc. 129, 11480-11490.
20. Holden, J. A., and Kelley, W. N. (1978) Human hypoxanthine-guanine phosphoribosyltransferase evidence for tetrameric structure. J. Biol. Chem. 253, 4459-4463.
21. Vos, S., de Jersey, J., and Martin, J. L. (1997) Crystal structure of Escherichia coli xanthine phosphoribosyltransferase. Biochemistry 36, 4125-4134.
22. Krambovitis, E., Porichis, F., and Spandidos, D. A. (2005) HIV entry inhibitors: a new gnenration of antiretroviral drugs. Acta. Pharmacol. Sin. 26, 1165-1173.
23. Dawson, P. E., Muir, T. W., Clark-Lewis, I., and Kent, S. B. H. (1994) Synthesis of proteins by native chemical ligation. Science 266, 776-779.
24. Muir, T. W., Sondhi, D., and Cole, P. A. (1998) Expressed protein ligation: A general method for protein engineering. Proc. Natl. Acad. Sci. U.S.A. 95, 6705-6710.
25. Erlanson, D. A., Chytil, M., and Verdine, G. L. (1996) The leucine zipper domain controls the orientation of AP-1 in the NFAT•AP-1•DNA complex. Chem. Biol. 3, 981-991.
26. Tolbert, T. J., and Wong, C-H. (2002) New methods for proteomic research: Preparation of proteins with N-terminal cysteines for labeling and conjugation. Angew. Chem., Int. Ed. 41, 2171-2174.
27. Tolbert, T. J., Franke, D., and Wong, C-H. (2005) A new strategy for glycoprotein synthesis: Ligation of synthetic glycopeptides with truncated proteins expressed in E. coli as TEV protease cleavable fusion protein. Bioorg. Med. Chem. 13, 909-915.
28. Marblestone, J. G., Edavettal, S. C., Lim, Y., Lim, P., Zuo, X., and Butt, T. R. (2006) Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO. Protein Sci. 15, 182-189.
29. Zuo, X., Li, S., Hall, J., Mattern, M. R., Tran, H., Shoo, J., Tan, R., Weiss, S. R., and Butt, T. R. (2005) Enhanced expression and purification of membrane proteins by SUMO fusion in Escherichia coli. J. Struct. Fund. Genom. 6, 103-111.
30. Butt, T. R., Edavettal, S. C., Hall, J. P., and Mattern, M. R. (2005) SUMO fusion technology for difficult-to-express proteins. Protein Expr. Purif. 43, 1-9.
31. Janciauskiene, S., García de Frutos, P., Carlemalm, E., Dahlbäck, B., and Eriksson, S. (1995) Inhibition of Alzheimer β-peptide fibril formation by serum amyloid P component. J. Biol. Chem. 270, 26041-26044.
32. Jarrett, J. T., and Lansbury, P. T., Jr. (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31, 12345-12352.
33. Jarrett, J. T., Berger, E. P., and Lansbury, P. T., Jr. (1993) The carboxy terminus of β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.